Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diazaspiro[4.5]decane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110177790B details a scalable resolution process for diazaspiro[4.5]decane derivatives, offering high enantiomeric excess and cost-effective manufacturing for pharmaceutical intermediates.
Novel hydrogenation-cyclization route offers high yield and mild conditions for scalable production of protected diazaspiro compounds.
Patent CN109651368A details a scalable two-step route for spiro compounds offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Solve supply chain risks for this key API intermediate with a 3-step industrial synthesis. 100% yield in first step, 51.3% in final step. Contact for GMP production.